B Complex Deficiency Signs That Look Like Early Cognitive Decline
Quick Read Some symptoms often blamed on aging, like brain fog and poor memory, may actually stem from B vitamin
Subscribe to the distribution list, to get regular updates on supplement research for health,
🧠 NeuroBright Our evidence-based brain supplement formulated from 1.7M research papers
Tiredness, brain fog, and hair loss in women over 40 may not be aging or menopause alone. Iron deficiency is the most common nutrient gap worldwide and disproportionately affects women. The critical discovery: you don’t need to be anaemic to feel terrible. Research shows that roughly 30% of women with iron deficiency have normal blood counts, yet experience 16 or more symptoms on average, including fatigue, memory problems, and feeling permanently cold.
Iron carries oxygen to your cells and is essential for mood-regulating chemicals in your brain. Studies show over one in three women of reproductive age in wealthy countries are iron deficient. Women in their 40s face a particular risk because heavier periods during perimenopause increase iron loss, yet doctors often attribute symptoms to hormones instead.
When iron deficiency is treated with oral supplements, fatigue scores drop significantly within 8 to 12 weeks, along with improvements in mental fog and physical energy. However, iron supplements can be harmful if you don’t actually have a deficiency, so testing is essential. A simple blood test measuring ferritin and transferrin saturation costs £30 to £60 and is the starting point before treatment.
Verdict: If you’re tired, get your iron levels tested, because deficiency is common in women over 40 and highly treatable, but only if you know your numbers first.
What if the exhaustion you’ve been quietly accepting, the kind that makes you reach for a third coffee, cancel plans, and wonder if you’re simply ageing, isn’t ageing at all? What if it’s a gap between what your body needs and what it’s actually getting? And what if that gap could be identified with a single blood test and addressed with something as straightforward as a supplement?
Iron deficiency is the most widespread micronutrient deficiency on the planet [2]. It disproportionately affects women, and it doesn’t just cause the anaemia your GP checks for. It causes fatigue, brain fog, hair loss, feeling permanently cold, poor sleep, and low mood, often long before your haemoglobin level drops a single point. The research is clear on this, and yet millions of women are being missed, told their bloods are “normal” and sent home to carry on. At Vitacuity, we’ve read through over 1.77 million research papers and selected the most relevant studies on this topic. What follows is what the evidence actually says.
To understand why iron matters so much, you need to know what it actually does inside your body.
Iron is the key component of haemoglobin, the protein in your red blood cells that carries oxygen from your lungs to every tissue and organ in your body. Without enough iron, your cells are essentially running on less fuel. That’s why the most obvious symptom of iron deficiency is fatigue: your muscles, brain, and heart are all getting less oxygen than they need to function properly [2].
But iron’s role goes further than oxygen transport. Iron is also essential for the production of neurotransmitters, the chemical messengers that regulate mood, focus, and cognitive function. It plays a role in dopamine and serotonin pathways, which is why low iron is linked not just to tiredness but to brain fog, low mood, irritability, and poor concentration [11]. It’s involved in myelin production, the protective coating around nerve fibres that helps signals travel efficiently in your brain [3].
When iron stores fall, even before anaemia develops, these systems start to falter. Your ferritin (the protein that stores iron in your body) drops first. Ferritin is the early warning signal, and it’s often the one that gets overlooked.
This is perhaps the most important finding in recent iron research, and it’s one that many GPs are still catching up with.
A 2025 study published in BMC Women’s Health analysed 239 female patients attending an iron deficiency clinic, all with ferritin below 30 mcg/L [4]. Researchers documented 41 distinct symptoms across these women. The average patient reported 16.5 symptoms. The ten most common were: weakness (87%), fatigue (82%), easy fatigability (79%), memory problems (72%), feeling cold (72%), hair loss (70%), cold intolerance (69%), sleep problems (67%), nervousness (63%), and cold feet (60%) [4].
Here’s the critical part: roughly 30% of those women were not anaemic. They had iron deficiency without anaemia, meaning their haemoglobin was technically normal. And yet their symptom profiles were remarkably similar to the women who were anaemic. In most of the 41 symptoms documented, there was no statistically significant difference between the anaemic and non-anaemic groups [4].
The study found that transferrin saturation (TSAT), a measure of how much of the body’s iron-carrying protein is actually loaded with iron, was the strongest correlate of symptom burden. Almost all women with positive symptoms had TSAT levels below 8% [4].
Evidence grade: Promising, this is a well-designed cross-sectional study of 239 patients, but it’s retrospective and based at a single hospital. It’s consistent with the broader picture, but larger prospective studies would strengthen the case further.
The numbers are striking. A 2025 review published in JAMA estimated that approximately 38% of non-pregnant women of reproductive age in high-income countries have iron deficiency without anaemia [2]. A further 13% have iron deficiency anaemia.
Read that again. More than one in three women of reproductive age, in wealthy, food-secure countries, are iron deficient. Not in some distant, malnourished population. Here. Now. Women who eat reasonably well, live normal lives, and probably think their tiredness is stress, perimenopause, or just the pace of modern life [2].
The most common causes? Menstrual blood loss, which can increase significantly during perimenopause, along with insufficient dietary iron intake, impaired absorption (which can worsen with age), and conditions like coeliac disease or inflammatory bowel disease [2].
Iron deficiency is diagnosed when ferritin falls below 30 ng/mL in the absence of inflammation, or when transferrin saturation falls below 20%. Testing is recommended for anyone experiencing fatigue, restless legs, or difficulty concentrating, and should be considered for any woman with heavy periods [2].
Evidence grade: Strong, this is a major JAMA review synthesising the available evidence base on iron deficiency epidemiology and diagnosis.
Women in their 40s face a particular double bind. The perimenopause transition can bring heavier, more irregular periods, increasing blood loss and therefore iron demand, at precisely the age when iron deficiency is least likely to be on anyone’s radar. The assumption, often made by both patients and clinicians, is that any symptoms in this phase are hormonal.
A 2025 review in the journal Nutrients examined the relationship between iron status and cognitive function in peri- and postmenopausal women [3]. The researchers noted that cognitive complaints, including memory problems, brain fog, and mental fatigue, are common during the menopause transition, and that while hormonal changes (particularly declining oestrogen) are the usual explanation, the evidence for hormone replacement therapy (HRT) treating cognitive symptoms is actually inconsistent.
The paper argues that iron deficiency may be an underappreciated contributor. Many women experience increased blood loss during perimenopause, which raises their risk of becoming iron deficient, and iron deficiency is already associated with impaired cognition, low mood, and fatigue in premenopausal women [3]. The researchers explicitly call for well-designed clinical trials in perimenopausal women to investigate whether iron supplementation could alleviate some of the cognitive and mood symptoms associated with this life stage [3].
Evidence grade: Early stage for the perimenopause-cognition-iron link specifically, the JAMA review on general iron deficiency is strong, and the connection between iron and cognition in younger women is reasonably well established, but the specific evidence in perimenopausal women is currently theoretical and needs direct testing. The call for research is warranted. The biological logic is sound.
So if you address iron deficiency, what actually improves? Let’s look at the specific trial data.
A 2025 pilot clinical trial published in PLOS ONE gave 23 women aged 18–30 with iron deficiency anaemia ferrous sulfate at 160 mg elemental iron per day for eight weeks [1]. The results were notable. General fatigue scores fell significantly (p<0.001). Physical fatigue fell significantly (p<0.001). Mental fatigue fell significantly (p<0.001). Reduced activity and reduced motivation scores also improved significantly. Haemoglobin increased by 17.62% and ferritin by 63.2% over the eight weeks [1].
Muscle endurance also improved significantly, though aerobic fitness and raw muscle strength did not. The researchers suggest this pattern makes sense: iron supplementation improves the efficiency of oxygen use in sustained activity, but may not be enough on its own to reverse structural muscle losses in the short term [1].
A separate 2025 study with 15 women with iron deficiency anaemia found that the same eight-week supplementation protocol improved postural control, reaction time, and proprioceptive accuracy, measures of how well the nervous system processes and responds to information [14]. These improvements were attributed to iron’s role in neural processing and attention [14].
A larger 2024 clinical study of 302 adults with non-anaemic to mildly anaemic iron deficiency compared a low-dose ferrous fumarate formula (Feroglobin) against standard iron supplements over 90 days [15]. The Feroglobin group saw ferritin levels rise by 442.87%, compared to 256.67% in the standard supplement group. Fatigue scale scores fell by 47.51%. Haemoglobin rose from a mean of 12.43 g/dL to 13.24 g/dL. All presenting health complaints resolved completely by 90 days [15]. Gastrointestinal side effects were similar between groups, and overall tolerability was good.
Evidence grade: Promising, these trials are small (15–302 participants), relatively short (8–12 weeks), and some lack control groups. But the direction of effect is consistent across studies: iron supplementation improves ferritin, reduces fatigue, and improves physical and cognitive performance in iron-deficient women. The effect sizes are meaningful, not marginal.
A 2013 systematic review published in the Journal of Nutritional Science looked at ten studies examining iron deficiency, cognition, mental health, and fatigue in women of childbearing age [11]. Seven of the ten studies reported improvement in cognitive test scores following iron treatment. Meta-analyses within the review found a significant improvement in arithmetic performance after iron treatment (p<0.01), though no significant effect was seen on digit span or block design tasks [11].
The review was honest about the limitations: study quality was variable, measures were inconsistent across studies, and the evidence base was relatively thin at the time. But the direction across most studies was clear, iron treatment improved function in iron-deficient women [11].
This is now over a decade old. The newer studies summarised above are consistent with its conclusions, and the science has only become more specific about the mechanisms involved.
Evidence grade: Promising, seven out of ten studies showed cognitive improvement with iron treatment; meta-analyses support some cognitive benefits, but study quality and consistency limited stronger conclusions.
Let’s be honest about the gaps, because they matter.
The perimenopause-specific evidence is thin. Almost all the intervention trials we have are in younger women, typically under 35. The 2025 Nutrients review makes a compelling case for why perimenopausal women deserve their own research, but those trials haven’t been done yet [3]. We’re extrapolating from younger populations, which is reasonable biologically, but it’s extrapolation.
Most trials are small and short. The largest intervention study here involved 302 people over 90 days [15]. That’s a reasonable start, but it’s not sufficient to understand long-term effects, optimal dosing strategies, or how different women (different ages, different causes of deficiency, different baseline ferritin levels) might respond differently.
Causality in cognition is still murky. The systematic review from 2013 noted that while cognition improves after iron treatment, the mechanisms aren’t fully established, and the evidence is heterogeneous [11]. The 2025 studies add to the picture, neural processing improvements, better postural control, faster reaction times, but we don’t yet have large, well-controlled trials in the perimenopausal population confirming these effects translate consistently.
The “normal” ferritin question is unresolved. The standard clinical threshold for iron deficiency is ferritin below 30 ng/mL. But some researchers argue this is too low, that symptoms can appear at ferritin levels well above this, and that “optimal” ferritin for energy and cognitive function may be considerably higher. The 2025 JAMA review uses 30 ng/mL as the diagnostic threshold [2], but the 2020 study of female runners found that nearly all were symptomatic at ferritin levels below 35 ng/mL [12], and some frameworks propose even higher thresholds for athletes. This remains an active area of debate.
We don’t know whether iron supplements help women who aren’t iron deficient. This is critical. The evidence for iron improving fatigue is specifically in women with confirmed deficiency. Supplementing without deficiency is not only potentially unhelpful but could be harmful, excess iron is not benign. Testing really does matter here.
Iron is genuinely different from most supplements we discuss. Unlike vitamin D, vitamin C, or magnesium, where a reasonable case can be made for supplementing widely given low risk and common deficiency, iron supplementation without testing is not advisable. Excess iron accumulates, can cause gastrointestinal problems, and in certain conditions (haemochromatosis, for example) can be dangerous. This is one area where “get tested first” is not a cop-out, it’s genuinely the right starting point.
But here’s where the practical advice diverges from the overly cautious. Testing for iron is not difficult, expensive, or inaccessible. A private blood test including ferritin and transferrin saturation costs between £30–£60 in the UK and can be done without a GP referral. Given that research suggests over one in three women of reproductive age in high-income countries are iron deficient [2], the probability that your tiredness, brain fog, hair loss, or poor sleep is related to iron status is far from negligible, particularly if you have heavy periods, are in your 40s, or eat little red meat.
What would a sensible, informed person do?
1. Get a ferritin test. Ask your GP, or get a private test. Ask specifically for ferritin and ideally transferrin saturation, not just a full blood count, which will only pick up anaemia, not early deficiency. A ferritin below 30 ng/mL is the diagnostic threshold; many practitioners consider below 50 ng/mL worth investigating in symptomatic women.
2. If you’re deficient, treat it seriously. Oral iron, ferrous sulfate, ferrous fumarate, or ferrous bisglycinate, is the first-line option. The 2025 JAMA review recommends ferrous sulfate 325 mg/day, or on alternate days to improve tolerability [2]. The clinical trial data suggests improvements in fatigue and ferritin are visible within 8–12 weeks [1][15]. Take iron with vitamin C to improve absorption; avoid taking it with tea, coffee, or calcium-rich foods.
3. If you’re perimenopausal and symptomatic, don’t assume it’s all hormonal. The cognitive symptoms, fatigue, and low mood of perimenopause may be exacerbated, or in some cases driven, by iron deficiency caused by heavier periods [3]. It’s worth ruling out before concluding that HRT is the only lever available.
4. If you exercise regularly, your ferritin threshold may be higher. The 2020 study of female recreational runners found nearly all participants had ferritin below levels considered adequate for active women [12]. If you run, cycle, swim, or train regularly, aim for ferritin above 35 ng/mL and consider discussing this with a sports medicine practitioner.
5. Retest after supplementing. A follow-up ferritin test at 12 weeks will tell you whether your levels have responded. If they haven’t, it’s worth investigating why, poor absorption, an underlying condition, or ongoing blood loss may need a different approach.
The bottom line: tiredness in your 40s and 50s is not inevitable, and it’s not all hormonal. Iron deficiency is common, systematically underdiagnosed in women who aren’t yet anaemic, and highly treatable. The research shows consistent, meaningful improvements in fatigue, mood, and cognitive function when deficiency is corrected. Get the test. Know your numbers. Then act.
[1] Efficacy of 8-week oral iron supplementation on fatigue and physical capacity in young women with iron deficiency anemia: An uncontrolled pilot clinical trial (2025). DOI: 10.1371/journal.pone.0334499 | https://pubmed.ncbi.nlm.nih.gov/41100554/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12530587/
[2] Iron Deficiency in Adults: A Review (2025). DOI: 10.1001/jama.2025.0452 | https://pubmed.ncbi.nlm.nih.gov/40159291/
[3] Cognitive Function in Peri- and Postmenopausal Women: Implications for Considering Iron Supplementation (2025). DOI: 10.3390/nu17111762 | https://pubmed.ncbi.nlm.nih.gov/40507031/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12157887/
[4] Beyond anemia: a comprehensive analysis of iron deficiency symptoms in women and their correlation with biomarkers (2025). DOI: 10.1186/s12905-025-03906-w | https://pubmed.ncbi.nlm.nih.gov/40721774/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12302447/
[11] Iron deficiency, cognition, mental health and fatigue in women of childbearing age: a systematic review (2013). DOI: 10.1017/jns.2013.7 | https://pubmed.ncbi.nlm.nih.gov/25191562/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153327/
[12] Ferritin readings in young adult, female university student recreational runners (2020). DOI: 10.1016/j.jtemb.2020.126617 | https://pubmed.ncbi.nlm.nih.gov/32653832/
[14] Eight weeks of oral iron supplementation improves postural control in young women with iron deficiency anemia (2025). DOI: 10.1038/s41430-024-01522-9 | https://pubmed.ncbi.nlm.nih.gov/39414981/
[15] A clinical study evaluating low dose ferrous fumarate vs. standard iron supplements in iron-deficient non-anemic to mild anemic adults (2024). https://pubmed.ncbi.nlm.nih.gov/38977742/
This article is for informational purposes only and does not constitute medical advice. Food supplements should not be used as a substitute for a varied and balanced diet and healthy lifestyle. If you are pregnant, breastfeeding, taking medication or have a medical condition, consult your doctor before taking any supplement. These statements have not been evaluated by the Food and Drug Administration (FDA) or the Medicines and Healthcare products Regulatory Agency (MHRA). This product is not intended to diagnose, treat, cure, or prevent any disease.
Quick Read Some symptoms often blamed on aging, like brain fog and poor memory, may actually stem from B vitamin
Quick Read Social isolation and loneliness physically shrink key brain regions responsible for memory, decision-making, and emotional processing. Research shows
Get notified about new articles